Combimatrix (CBMX) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Combimatrix (CBMX)

CBMX 6.250

0.0%

Nov 16 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Paul Lee	9/22/2008 8:22:32 AM
	of 237

2009 Defense Appropriations Bill Includes $2 Million for CombiMatrix Monday September 22, 6:00 am ET MUKILTEO, Wash., Sept. 22, 2008 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (NasdaqGM:CBMX - News) announced that U.S. Senator Patty Murray (D-WA) has included $2 million in the 2009 Defense Appropriations Bill for development of a Health Surveillance System by the company. The funding was included in the version of the legislation approved by the Senate Defense Appropriations Subcommittee on September 10. The system, to be developed under the management of the Air Force Research Laboratory, builds on CombiMatrix's versatile semiconductor microarray and instrumentation platforms to detect changes in body chemistry as a result of trauma. ``With this funding, CombiMatrix will further develop its microarray platform technology to provide the military healthcare system with new tools for treating everything from bullet wounds to battlefield stress,'' said Dr. David Danley, Director of Homeland Security and Defense Programs at CombiMatrix. ``Early surgical intervention to repair wounded tissue saves lives and limbs. However, it is becoming more evident that stress and trauma can have long-term effects on the body even without overt physical damage. This funding would allow us to develop new assays on our microarray platform to identify changes in body chemistry and gene expression that are indicative of adverse changes in physiological performance. We want to provide military health care providers with new tools for evaluating the adverse and long-term effects of stress and trauma. In addition, the work enabled by this funding will be relevant to similar applications in the civilian market space. We are enormously grateful to Senator Murray for her support of the vital project. The availability of the funding is contingent upon final enactment of the provision into law.'' Senator Murray's press release can be read at murray.senate.gov .

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next